Markus H. Frank

9.8k total citations · 2 hit papers
126 papers, 6.4k citations indexed

About

Markus H. Frank is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Markus H. Frank has authored 126 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 43 papers in Oncology and 25 papers in Immunology. Recurrent topics in Markus H. Frank's work include Cancer Cells and Metastasis (24 papers), Immunotherapy and Immune Responses (19 papers) and Drug Transport and Resistance Mechanisms (13 papers). Markus H. Frank is often cited by papers focused on Cancer Cells and Metastasis (24 papers), Immunotherapy and Immune Responses (19 papers) and Drug Transport and Resistance Mechanisms (13 papers). Markus H. Frank collaborates with scholars based in United States, Germany and Australia. Markus H. Frank's co-authors include Tobias Schatton, Natasha Y. Frank, Gëorge F. Murphy, Mohamed H. Sayegh, Martin Gasser, Ana Maria Waaga-Gasser, Qian Zhan, Thomas S. Kupper, Carsten Weishaupt and Brian J. Wilson and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Markus H. Frank

121 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of cells initiating human melanomas

2008 1.1k citations Tobias Schatton, Gëorge F. Murphy et al. profile →
The therapeutic promise of the cancer stem cell concept

2010 524 citations Natasha Y. Frank, Tobias Schatton et al. profile →

Peers

Countries citing papers authored by Markus H. Frank

Since Specialization

Citations

This map shows the geographic impact of Markus H. Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus H. Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus H. Frank more than expected).

Fields of papers citing papers by Markus H. Frank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus H. Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus H. Frank. The network helps show where Markus H. Frank may publish in the future.

Co-authorship network of co-authors of Markus H. Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Markus H. Frank. A scholar is included among the top collaborators of Markus H. Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus H. Frank. Markus H. Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Mark A. Kluth, Christoph Ganss, Markus H. Frank, Natasha Y. Frank, Bruce R. Ksander, Claus Cursiefen, Maria Notara	1
2	Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa–Associated Cutaneous Squamous Cell Carcinoma 2024 ·Journal of Investigative Dermatology ·Catherine Lee, (unknown), (unknown), Eric Kofman, (unknown), Megan Riddle, Cindy Eide, Christen L. Ebens, Markus H. Frank, Jakub Tolar, Kristen P. Hook, Saud H. AlDubayan, Natasha Y. Frank	1
3	ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa 2023 ·Cytotherapy ·(unknown), Elke Niebergall‐Roth, (unknown), (unknown), Natasha Y. Frank, Christoph Ganss, Dimitra Kiritsi, John A. McGrath, Jakub Tolar, Markus H. Frank, Mark A. Kluth	10
4	ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation 2023 ·Cells ·(unknown), (unknown), (unknown), (unknown), Yanhong Hou, Mark A. Kluth, Christoph Ganss, Markus H. Frank, Natasha Y. Frank, Bruce R. Ksander, Claus Cursiefen, Maria Notara	3
5	ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo 2023 ·Stem Cell Research & Therapy ·Kaixuan Yan, (unknown), Mark A. Kluth, Lin Li, Christoph Ganss, Benito Yard, Richard Magdeburg, Markus H. Frank, (unknown), Michael Keese	2
6	Limbal BCAM expression identifies a proliferative progenitor population capable of holoclone formation and corneal differentiation 2022 ·Cell Reports ·Yuzuru Sasamoto, Catherine Lee, Brian J. Wilson, Florian Buerger, (unknown), (unknown), (unknown), Johnathan Tran, Gabriel González, Friedhelm Hildebrandt, Vickie Y. Jo, Christine G. Lian, Gëorge F. Murphy, Bruce R. Ksander, Markus H. Frank, Natasha Y. Frank	10
7	Loss of the Epigenetic Mark 5-hmC in Psoriasis: Implications for Epidermal Stem Cell Dysregulation 2019 ·Journal of Investigative Dermatology ·(unknown), (unknown), Shuyun Xu, (unknown), (unknown), Catherine Lee, (unknown), Michael Wells, Matthew R. Ramsey, Natasha Y. Frank, Xunwei Wu, Anna Mandinova, Markus H. Frank, Christine G. Lian, Gëorge F. Murphy	22
8	In vitro expanded human purified ABCB5-positive limbal stem cells for treatment of limbal stem cell deficiency. 2018 ·Investigative Ophthalmology & Visual Science ·Bruce R. Ksander, Ekaterina Korobkina, Christoph Ganss, (unknown), Natasha Y. Frank, Markus H. Frank	1
9	UV light-blocking contact lenses protect against short-term UVB-induced limbal stem cell niche damage and inflammation 2018 ·Scientific Reports ·Maria Notara, (unknown), Mark A. Kluth, (unknown), Christoph Ganss, Markus H. Frank, Björn Schumacher, Claus Cursiefen	22
10	Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells 2017 ·Laboratory Investigation ·Beau R. Webber, (unknown), Ron McElmurry, (unknown), Cindy Eide, Christopher J. Lees, Megan Riddle, Wendy Mathews, Natasha Y. Frank, Mark A. Kluth, Christoph Ganss, Branden S. Moriarity, Markus H. Frank, Mark J. Osborn, Jakub Tolar	29
11	ABCB5 identifies RPE progenitor cells required for normal retinal development and aging 2016 ·Investigative Ophthalmology & Visual Science ·Bruce R. Ksander, Andrew Hertsenberg, (unknown), Brian J. Wilson, (unknown), Markus H. Frank, Natasha Y. Frank	1
12	Effects of Malignant Melanoma Initiating Cells on T-Cell Activation 2015 ·Methods in molecular biology ·Tobias Schatton, Ute Schütte, Markus H. Frank	2
13	Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment 2015 ·Journal of Investigative Dermatology ·Elin S. Gray, Anna Reid, Samantha Bowyer, Leslie Calapre, Kelvin Shenq Woei Siew, Robert Pearce, Lester Cowell, Markus H. Frank, Michael Millward, Mel Ziman	64
14	ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit 2014 ·Cancer Research ·Brian J. Wilson, Karim R. Saab, Jie Ma, Tobias Schatton, (unknown), Qian Zhan, Gëorge F. Murphy, Martin Gasser, Ana Maria Waaga-Gasser, Natasha Y. Frank, Markus H. Frank	116
15	ABCB5 Identifies a Therapy-Refractory Tumor Cell Population in Colorectal Cancer Patients 2011 ·Cancer Research ·Brian J. Wilson, Tobias Schatton, Qian Zhan, Martin Gasser, Jie Ma, Karim R. Saab, (unknown), (unknown), Jason S. Gold, Qin Huang, Gëorge F. Murphy, Markus H. Frank, Natasha Y. Frank	113
16	VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth 2011 ·Cancer Research ·Natasha Y. Frank, Tobias Schatton, Soo‐Jeong Kim, Qian Zhan, Brian J. Wilson, Jie Ma, Karim R. Saab, (unknown), Hans R. Widlund, Martin Gasser, (unknown), Thomas S. Kupper, Gëorge F. Murphy, Markus H. Frank	133
17	Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells 2010 ·Cancer Research ·Tobias Schatton, Ute Schütte, Natasha Y. Frank, Qian Zhan, André Hoerning, (unknown), Jun Zhou, F. Stephen Hodi, Giulio C. Spagnoli, Gëorge F. Murphy, Markus H. Frank	238
18	Specific MDR1 P-Glycoprotein Blockade Inhibits Human Alloimmune T Cell Activation In Vitro 2001 ·The Journal of Immunology ·Markus H. Frank, Mark Denton, Stephen I. Alexander, Samia J. Khoury, Mohamed H. Sayegh, David M. Briscoe	61
19	Prevalence and epidemiological significance ofTrypanosoma cruzi infection among latin american immigrants in Berlin, Germany 1997 ·Infection ·Markus H. Frank, B Hegenscheid, K. Janitschke, Thomas Weinke	40
20	ROP volume 13 issue 2 Cover and Front matter 1951 ·The Review of Politics ·Robert F. Byrnes, (unknown), (unknown), (unknown), Waldemar Gurian, (unknown), Markus H. Frank, (unknown), (unknown), W. L. Nutting, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact